Covista Inc. (CVSA)

NYSE: CVSA · Real-Time Price · USD
126.01
-0.01 (-0.01%)
At close: May 20, 2026, 4:00 PM EDT
126.01
0.00 (0.00%)
After-hours: May 20, 2026, 4:10 PM EDT
Market Cap4.29B +1.0%
Revenue (ttm)1.91B +9.7%
Net Income234.06M +0.8%
EPS6.43 +6.7%
Shares Out 34.03M
PE Ratio19.60
Forward PE15.08
Dividendn/a
Ex-Dividend Daten/a
Volume344,450
Open125.68
Previous Close126.02
Day's Range122.72 - 126.73
52-Week Range86.97 - 156.26
Beta0.63
AnalystsStrong Buy
Price Target156.25 (+24.0%)
Earnings DateMay 7, 2026

About CVSA

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor’s, master’s, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public adm... [Read more]

Founded 1987
Employees 4,750
Stock Exchange NYSE
Ticker Symbol CVSA
Full Company Profile

Financial Performance

In fiscal year 2025, Covista's revenue was $1.79 billion, an increase of 12.85% compared to the previous year's $1.58 billion. Earnings were $237.07 million, an increase of 73.32%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for CVSA stock is "Strong Buy." The 12-month stock price target is $156.25, which is an increase of 24.00% from the latest price.

Price Target
$156.25
(24.00% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Chamberlain University to Open Cincinnati Campus, Accepting Applications for Fall 2026

CHICAGO--(BUSINESS WIRE)--Chamberlain University, the nation's largest school of nursing and a Covista institution, today announced it will open a new campus in Cincinnati, Ohio. The Cincinnati campus...

1 day ago - Business Wire

Covista price target raised to $140 from $130 at Truist

Truist raised the firm’s price target on Covista (CVSA) to $140 from $130 and keeps a Buy rating on the shares after its Q3 earnings beat. The firm is citing…

9 days ago - TheFly

Covista Earnings Call Transcript: Q3 2026

Enrollment growth drove record results and raised guidance, with strong performance across all segments. Strategic investments in AI, campus expansion, and partnerships, plus robust cash flow and capital allocation, position the platform for continued growth.

12 days ago - Transcripts

Covista Slides: Q3 2026

Covista has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on May 7, 2026.

12 days ago - Filings

Covista Earnings release: Q3 2026

Covista released its Q3 2026 earnings on May 7, 2026, summarizing the period's financial results.

12 days ago - Filings

Covista Quarterly report: Q3 2026

Covista has published its Q3 2026 quarterly earnings report on May 7, 2026.

12 days ago - Filings

Covista reports Q3 adjusted EPS $1.98, consensus $1.72

Reports Q3 revenue $487.03M, consensus $474.04M. “The country needs more nurses, physicians, and behavioral health professionals than the current system is on pace to produce. Covista (CVSA) is helpin...

12 days ago - TheFly

Covista raises FY26 adjusted EPS view to $7.95-$8.15 from $7.80-$8.00

Consensus is $7.91. Raises FY revenue view to $1.93B-$1.945B from $1.9B-$1.94B, consensus $1.92B.

12 days ago - TheFly

Covista Third Quarter Fiscal Year 2026 Results; Raises Fiscal Year 2026 Revenue and Adjusted Earnings Per Share Guidance

CHICAGO--(BUSINESS WIRE)--Covista Inc. (NYSE: CVSA), the largest healthcare educator in the United States, today reported third quarter fiscal year 2026 results (ended Mar. 31, 2026). The Company cont...

13 days ago - Business Wire

Covista medical schools achieve 97% first-time residency attainment rate

Covista (CVSA) announced a combined 97% first-time residency attainment rate for its 2025-2026 graduating class at Ross University School of Medicine, RUSM, and American University of the Caribbean Sc...

27 days ago - TheFly

Covista Medical Schools Achieve 97% Combined First-Time Residency Attainment Rate

CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced a combined 97% first-time residency attainment rate* for its 2025-2026 graduating class at Ross U...

27 days ago - Business Wire

Covista Announces AI-Powered Classroom of the Future for Healthcare Education with Google Cloud

CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced that the healthcare AI credentials Covista and Google Cloud launched together in October are now ...

5 weeks ago - Business Wire

Covista announces Amelia Manning as president, Chamberlain University

Covista (CVSA) announced that Amelia Manning has been named president of Chamberlain University, effective May 18. Most recently, Manning served as the Dean of Tulane University’s School of Profession...

5 weeks ago - TheFly

Amelia Manning Named as the Next President of Chamberlain University

CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced that Amelia Manning has been named president of Chamberlain University, effective May 18, 2026. M...

5 weeks ago - Business Wire

Covista Announces Third Quarter Fiscal Year 2026 Conference Call

CHICAGO--(BUSINESS WIRE)--Covista (the "company" or "Covista") (NYSE: CVSA), the largest healthcare educator in the United States, announced today it will release its third quarter fiscal year 2026 re...

6 weeks ago - Business Wire

Covista announces Betz has been named Chief Growth & Innovation Officer

Covista (CVSA) announced that Michael Betz has been named Chief Growth & Innovation Officer, expanding his responsibilities to include oversight of the company’s Marketing organization while retaining...

6 weeks ago - TheFly

Covista Expands Michael Betz's Role to Chief Growth & Innovation Officer

CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced that Michael Betz has been named Chief Growth & Innovation Officer, expanding his responsibilitie...

6 weeks ago - Business Wire

Covista initiated with a Buy at Truist

Truist initiated coverage of Covista (CVSA), formerly Adtalem, with a Buy rating and $130 price target The company’s clinical healthcare-focused institutions should benefit from labor shortages and up...

2 months ago - TheFly

Covista Transcript: Investor Day 2026

Covista unveiled its 'Purpose at Scale' strategy, targeting 7%-10% revenue CAGR and 10%-14% EPS CAGR through 2029, driven by aggressive campus expansion, digital innovation, and deep employer partnerships. The company is leveraging its scale, AI integration, and disciplined capital allocation to address the U.S. healthcare workforce crisis and deliver double-digit earnings growth.

3 months ago - Transcripts

Covista Slides: FY 2026

Covista has posted slides in relation to its FY 2026 quarterly earnings report, which was published on February 24, 2026.

3 months ago - Filings

Covista Unveils Strategic Plan for Continued Momentum and Long-Term Value Creation at Investor Day

CHICAGO--(BUSINESS WIRE)--Covista (the "company" or "Covista") (NYSE: ATGE), today will host its Investor Day beginning at 9 a.m. ET. Covista is America's largest healthcare educator, serving more tha...

3 months ago - Business Wire

Ross University School of Medicine Welcomes New Dean

CHICAGO--(BUSINESS WIRE)--Covista (NYSE: ATGE), America's largest healthcare educator, today announced Cheryl Holmes, M.D., a fellow of the Royal College of Physicians of Canada with a master's degree...

3 months ago - Business Wire

Adtalem Global Education Becomes Covista

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education (NYSE: ATGE) today announced it is changing its name to Covista, marking the culmination of a four-year transformation to become America's largest he...

3 months ago - Business Wire

Covista Earnings Call Transcript: Q2 2026

Enrollment and revenue grew strongly across all segments, with Walden and Medical/Vet leading gains. Adjusted EPS guidance was raised to 17%-20% growth, and a new $750M share repurchase authorization was announced.

3 months ago - Transcripts

Covista Quarterly report: Q2 2026

Covista has published its Q2 2026 quarterly earnings report on January 28, 2026.

3 months ago - Filings